3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
1
Conditions
Colonic Neoplasms
9
Colorectal Neoplasms
6
Esophageal Neoplasms
4
Rectal Neoplasms
3
Liver Neoplasms
3
Gallbladder Neoplasms
3
Carcinoma, Hepatocellular
3
Anus Neoplasms
3
Stomach Neoplasms
2
Squamous Intraepithelial Lesions
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Neoplasms
2
HIV Infections
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms, Male
2
Breast Neoplasms
2
Bile Duct Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Thromboembolism
1
Thrombocythemia, Essential
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Observation
2
Watchful Waiting
1
Trichloroacetic Acid
1
Therapeutics
1
Rapid Diagnostic Tests
1
Light Coagulation
1
Laser Therapy
1
Isotretinoin
1
Interferon alpha-2
1
Imiquimod
1
Fluorouracil
1
Enzyme-Linked Immunosorbent Assay
1
Electrocoagulation
1
Anti-HIV Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acquired Immunodeficiency Syndrome
×
Watchful Waiting
×
Gastrointestinal
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts